Imidazo[2,1-b]benzothiazoles. I

DOI: 10.1248/cpb.36.4760

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 4760 - 4768 (1988)

Update date:2022-08-03

Topics:

Authors:

El-Shorbagi

Sakai Sakai

El-Gendy

Omar Omar

Farag Farag

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.36.4760

Full text of DOI:10.1248/cpb.36.4760

Products guided by the article

Product name:2-(2-Imino-benzothiazol-3-yl)-1-(4-methoxy-phenyl)-ethanone; hydrobromide

Cas No:99582-73-7

R&D Labs maybe for 99582-73-7

LABTER PARMATECH(BEIJING)CO.,LTD

website:http://www.labter.com.cn/

Contact:+86-10-56330744

Address:NO.19,TIANRONG STREET,DAXING BIOMEDICIAL BASE ,ZHONGGUANCUN SCIENCE AND TECHNOLOGY PARK,BEIJING ,CHINA
YORK CHEMICALS LTD

Contact:+1 (647) 918 5848

Address:2343 BRIMLEY RD., Suite 250
Tianjin Ingenochem Technology Co.,Ltd

Contact:+86-22-23677060

Address:Hitech Green Industry Park K2-9-602, Nankai district
Shandong Xinke Petrochemical Co., Ltd.

Contact:+86-546-7277016

Address:Gudao Industrial Park, Hekou District, Dongying, Shandong Province, China
Xiamen Goodhealth Pharmchem Co., Ltd.

Contact:0086-592-2097683

Address:404R No.2 54# Minzu Rd., Xiamen, China

Relevant to this article

Doi:10.1021/ja01512a058
(1959)
Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I gatekeeper Mutant of cKIT Kinase

Doi:10.1021/acs.jmedchem.6b00902
(2016)
Doi:10.1021/ja01258a011
(1942)
An optimized procedure for direct access to 1: H -indazole-3-carboxaldehyde derivatives by nitrosation of indoles

Doi:10.1039/c8ra01546e
(2018)
Remarkable β-selectivity in the synthesis of β-1-C- arylglucosides: Stereoselective reduction of acetyl-protected methyl 1-C-arylglucosides without acetoxy-group participation

Doi:10.1021/jo071051i
(2007)
Doi:10.1016/S0040-4039(00)62045-2
(1962)

Article Doi